AI-generated analysis for informational purposes only. Not financial advice.
Crunching the numbers…
Crunching the numbers…
Price between its moving averages. RSI 37 — neutral.
Sign in to connect your holdings with this analysis.
Sign in to track this thesis — we'll watch whether the assumptions behind it still hold and flag any drift.
An absolute −99…+99 blend of news tone and recent price momentum, with a quarter-over-quarter delta (the change matters more than the level). This differs from the peer-relative Sentiment dimension in the score above — which ranks news tone vs comparable names — so a name can read “Bullish” here on momentum while its score Sentiment sits lower vs peers. Per-headline tags come from a finance lexicon on the headline text only (not the full article) — a fast heuristic that can misread sarcasm or a mixed headline, so treat them as a rough cue, not a judgment.
Peer-relative, six dimensions at a glance.
Logistic model on real price features (980 real samples). A weak directional signal, not a forecast — see Track Record for the honest out-of-sample score. Not advice.
Fair value needs real positive free-cash-flow data, which is not available for this ticker right now.
A distribution of outcomes over 5Y, not a single price target.
Median 1.57x vs a diversified market’s 1.49x over the same horizon — this name’s outlook is above the market (both medians, so the comparison is fair).
| Regime | Chance | Return / year |
|---|---|---|
| Bull | 20% | +35% |
| Base | 43% | +11% |
| Bear | 20% | -1% |
| Stress | 7% | -23% |
| Ruin | 11% | -60% |
Why these numbers: the regimes center on an expected return of +10.8%/yr — the three sources of a stock's return: income (0.0% dividend) + earnings growth (+15.0%/yr, capped for prudence), anchored toward the 8% long-run market average (it trades near DCF fair value, so no valuation tilt). The band's width comes from 33% realized volatility — modeled log-normally with the volatility drag and fat tails priced in, plus uncertainty in the estimate itself, so it widens correctly over longer horizons. Not advice.
Consensus median across 30 analyst price targets. Individual per-firm targets aren’t shown.